2,694
Views
5
CrossRef citations to date
0
Altmetric
Tuberculosis

Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes

ORCID Icon, , , , ORCID Icon, & ORCID Icon show all
Pages 1973-1981 | Received 27 Mar 2022, Accepted 14 Jul 2022, Published online: 08 Aug 2022

References

  • Daley C, Iaccarino J, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. Clin Infect Dis. 2020;71(4):905–913.
  • Griffith D. Therapy of nontuberculous mycobacterial disease. Curr Opin Infect Dis. 2007;20(2):198–203.
  • Angenent L, Kelley S, St Amand A, et al. Molecular identification of potential pathogens in water and air of a hospital therapy pool. Proc Natl Acad Sci U S A. 2005;102(13):4860–4865.
  • Al-Busaidi I, Wong D, Boggild AK. Cutaneous Mycobacterium gordonae infection in an elderly diabetic returned traveller. J Travel Med. 2017;24(5).
  • Chang H, Tsai W, Lee T, et al. Mycobacterium gordonae infection in immunocompromised and immunocompetent hosts: A series of seven cases and literature review. J Formos Med Assoc. 2021;120:524–532.
  • Chen Y, Jiang J, Jiang H, et al. Mycobacterium gordonae in patient with facial ulcers, nosebleeds, and positive T-SPOT.TB test, China. Emerg Infect Dis. 2017;23(7):1204–1206.
  • Kim B, Hong S, Kook Y, et al. Mycobacterium paragordonae sp. nov., a slowly growing, scotochromogenic species closely related to Mycobacterium gordonae. Int J Syst Evol Microbiol. 2014;64:39–45.
  • Kaelin M, Kuster S, Hasse B, et al. Diversity of nontuberculous mycobacteria in heater-cooler devices - results from prospective surveillance. J Hosp Infect. 2020 Mar 6:S0195-6701(20)30105-5.
  • Takajo I, Iwao C, Aratake M, et al. Pseudo-outbreak of Mycobacterium paragordonae in a hospital: possible role of the aerator/rectifier connected to the faucet of the water supply system. J Hosp Infect. 2020;104(4):545–551.
  • Pereira S, Alarico S, Tiago I, et al. Studies of antimicrobial resistance in rare mycobacteria from a nosocomial environment. BMC Microbiol. 2019;19(1):62.
  • Tan Y, Yuan T, Tan L, et al. Mycobacterium paragordonaeLumbar infection caused by: a case report. World J Clin Cases. 2021;9(29):8879–8887.
  • Kim B, Kim B, Kook Y, et al. A temperature sensitive Mycobacterium paragordonae induces enhanced protective immune responses against mycobacterial infections in the mouse model. Sci Rep. 2017;7(1):15230.
  • Wayne L. International Committee on Systematic Bacteriology: announcement of the report of the ad hoc Committee on Reconciliation of Approaches to Bacterial Systematics. Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Jun;268(4):433–434.
  • Griffith D, Aksamit T, Brown-Elliott B, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.
  • Kim B, Jeong H, Seo H, et al. Mycobacterium paragordonaerecombinant expressing SARS-CoV-2 receptor-binding domain as a vaccine candidate against SARS-CoV-2 infections. Front Immunol. 2021;12:712274.
  • Kim B, Kim B, Kook Y, et al. Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection. Sci Rep. 2019;9(1):15515.
  • Moradi S, Nasiri M, Pourahmad F, et al. Molecular characterization of nontuberculous mycobacteria in hospital waters: a two-year surveillance study in Tehran, Iran. J Water Health. 2019;17(2):350–356.
  • Azadi D, Shojaei H, Pourchangiz M, et al. Species diversity and molecular characterization of nontuberculous mycobacteria in hospital water system of a developing country, Iran. Microb Pathog. 2016;100:62–69.
  • Azadi D, Shojaei H, Mobasherizadeh S, et al. Screening, isolation and molecular identification of biodegrading mycobacteria from Iranian ecosystems and analysis of their biodegradation activity. AMB Express. 2017;7(1):180.
  • Cheung C, Cheng N, Ting W, et al. Mycobacterium paragordonae: a rare cause of peritonitis in a peritoneal dialysis patient. Clin Nephrol. 2017;88(12):371–372.
  • Lee S, Yang S, Choi Y, et al. Heat-killed Mycobacterium paragordonae therapy exerts an anti-cancer immune response via enhanced immune cell mediated oncolytic activity in xenograft mice model. Cancer Lett. 2020;472:142–150.